Katsuhito Ogawa
Nagoya University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Katsuhito Ogawa.
British Journal of Pharmacology | 1989
Katsuhito Ogawa; Kenzo Takagi; Tatsuo Satake
1 Four 3‐alkylxanthines (3‐methylxanthine, 3‐n‐propylxanthine (enprofylline), 3‐n‐butylxanthine and 3‐iso‐butylxanthine) and four 1‐methyl‐3‐alkylxanthines (1‐methyl‐3‐methylxanthine (theophylline), 1‐methyl‐3‐n‐propylxanthine, 1‐methyl‐3‐n‐butylxanthine and 1‐methyl‐3‐iso‐butylxanthine (IBMX)), were compared in terms of cyclic AMP phosphodiesterase (PDE) inhibition and trachealis muscle relaxation. The relationship between xanthine structure and cyclic AMP PDE inhibition was also studied. 2 Xanthine induced relaxation of guinea‐pig isolated trachealis muscle was measured against spontaneous tone. 3 The four 1‐methyl‐3‐alkylxanthines were each significantly more potent than the corresponding 3‐alkylxanthines in relaxing the isolated trachealis muscle. The 1‐methyl‐3‐alkylxanthines were similarly more potent than the corresponding 3‐alkyl derivatives in inhibiting low Km cyclic AMP PDE. There was a strong positive correlation between low Km cyclic AMP PDE inhibition and the tracheal smooth muscle relaxation evoked by the xanthine derivatives. 4 Since methylation of the 1‐position of each 3‐alkylxanthine increased the potency of the derivative in inhibiting low Km cyclic AMP PDE and in relaxing trachealis muscle and since a strong positive correlation was observed between the relaxant EC50 and the Ki value of each xanthine derivative, it is suggested that low Km cyclic AMP PDE inhibition by xanthines plays an important role in their tracheal relaxant effect.
British Journal of Pharmacology | 1989
Kazumi Kanda; Katsuhito Ogawa; Norihiro Miyamoto; Takashi Hatano; Hisao Seo; Nobuo Matsui
1 The effect of steroid hormones on atrial natriuretic peptide (ANP)‐stimulated cyclic guanosine monophosphate (cyclic GMP) formation was studied in cultured rat renal cells. 2 ANP increased cyclic GMP formation in a dose‐dependent manner, while cyclic AMP was not changed by ANP. 3 Steroid hormones did not affect basal cyclic GMP levels in cultured rat renal cells. 4 Dexamethasone at 10−8m increased ANP (human and rat ANP)‐stimulated cyclic GMP dose‐dependently in cultured rat renal cells. Cortisol, corticosterone and aldosterone at a concentration of 10−7m also potentiated ANP‐stimulated cyclic GMP formation, although triiodothyronine, oestradiol and testosterone were ineffective. Potentiation of ANP action by these steroids seems to parallel glucocorticoid activity. 5 Dexamethasone did not affect cyclic GMP formation stimulated by sodium nitroprusside which stimulates soluble guanylate cyclase in the cytosol. Therefore, the potentiating action of dexamethasone may be mediated through the action on particulate guanylate cyclase at the plasma membrane. 6 It is suggested that the diuretic action of glucocorticoids may, at least in part, be mediated through the potentiating effect of glucocorticoids on cyclic GMP response to ANP.
European Journal of Pharmacology | 1991
Kazumi Kanda; Norihiro Miyamoto; Hisao Seo; Katsuhito Ogawa; Takashi Hatano; Nobuo Matsui
The present study was undertaken to examine whether sulfonamide-derived diuretics affect [Arg8]vasopressin (AVP)-stimulated or atrial natriuretic peptide (ANP)-stimulated cyclic nucleotide formation in cells cultured from rat or dog kidney. In rat renal cells, all four sulfonamide-derived diuretics examined significantly suppressed 10(-9) M AVP-stimulated cAMP formation at concentrations of 10(-4) and 10(-3) M, while basal cAMP formation was unchanged by the diuretics. When cells were stimulated with 10(-7) M AVP, low ceiling diuretics (indapamide and trichlormethiazide) did not suppress cAMP formation, while high ceiling diuretics (furosemide and azosemide) significantly suppressed cAMP formation at concentrations of 10(-4) and 10(-3) M. The suppressive effect of the diuretics on AVP-stimulated cAMP formation in vitro paralleled the reported diuretic potency of the agents in vivo. In dog renal cells, all four diuretics significantly suppressed 10(-9) M AVP-stimulated cAMP formation at concentrations from 10(-6) to 10(-5) M, while these diuretics did not change basal cAMP levels. High ceiling diuretics suppressed 10(-7) M AVP-stimulated cAMP formation, whereas low ceiling diuretics did not. The difference in effective doses between rats and dogs seems to be consistent with the species difference observed in vivo. None of the diuretics affected basal levels of intracellular cGMP or ANP-stimulated cGMP formation in cultured rat renal cells. In addition to the inhibition of the Na/K/Cl co-transporter, it is suggested that most sulfonamide-derived diuretics act, at least in part, by inhibiting the actions of AVP.
The Journal of Clinical Endocrinology and Metabolism | 1983
Katsuhito Ogawa; Kaori Sueda; Nobuo Matsui
Endocrinologia Japonica | 1988
Takashi Hatano; Katsuhito Ogawa; Kazumi Kanda; Hisao Seo; Nobuo Matsui
Endocrinologia Japonica | 1983
Kaori Sueda; Katsuhito Ogawa; Nobuo Matsui
Endocrinologia Japonica | 1985
Takashi Hatano; Katsuhito Ogawa; Masahiro Yamamoto; Kazumi Kanda; Nobuo Matsui
European Journal of Endocrinology | 1988
Tsunenori Takano; Kensuke Takatsuki; Masahiro Yoneda; Akio Tomita; Katsuhito Ogawa; Nobuo Matsui
Endocrinologia Japonica | 1986
Katsuhito Ogawa; Nobuo Matsui
European Journal of Pharmacology | 1990
H. Tanaka; Katsuhito Ogawa; Kenzo Takagi; Tatsuo Satake